Plasma clearance of RAS mutation under therapeutic pressure is a rare event in metastatic colorectal cancer

被引:0
|
作者
Moati, E. [1 ]
Blons, H. [2 ]
Taly, V. [3 ]
Garlan, F. [3 ]
Shu-Fang, W-R. [3 ]
Pietrasz, D. [3 ]
Didelot, A. [3 ]
Garrigou, S. [3 ]
Saint, A. [4 ]
Pernot, S. [1 ]
Taieb, J. [1 ]
Laurent-Puig, P. [3 ]
Zaanan, A. [1 ]
机构
[1] Hop Europeen Georges Pompidou, Dept Gastroenterol & Digest Oncol, Paris, France
[2] Hop European George Pompidou, Mol Oncol, Paris, France
[3] Univ Paris Diderot, Univ Paris Descartes, Sorbonne Univ, Ctr Rech Cordeliers,USPC,CNRS,INSERM, Paris, France
[4] Hop European George Pompidou, Oncol Digest, Paris, France
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
623P
引用
收藏
页码:236 / 236
页数:1
相关论文
共 50 条
  • [1] Plasma clearance of RAS mutation under therapeutic pressure is a rare event in metastatic colorectal cancer
    Moati, Emilie
    Blons, Helene
    Taly, Valerie
    Garlan, Fanny
    Wang-Renault, Shu-Fang
    Pietrasz, Daniel
    Didelot, Audrey
    Garrigou, Sonia
    Saint, Angelique
    Pernot, Simon
    Taieb, Julien
    Laurent-Puig, Pierre
    Zaanan, Aziz
    INTERNATIONAL JOURNAL OF CANCER, 2020, 147 (04) : 1185 - 1189
  • [2] RAS mutation clearance in patients with metastatic colorectal cancer
    Huiyan, L.
    Wang, Z.
    Lin, W.
    Wang, Z.
    Xu, R.
    ANNALS OF ONCOLOGY, 2020, 31 : S444 - S444
  • [3] Why the Therapeutic Impact of RAS Mutation Clearance in Plasma ctDNA Deserves to Be Further Explored in Metastatic Colorectal Cancer
    Nicolazzo, Chiara
    Belardinilli, Francesca
    Caponnetto, Salvatore
    Gradilone, Angela
    Cortesi, Enrico
    Giannini, Giuseppe
    Gazzaniga, Paola
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [4] Circulating Methylated DNA to Monitor the Dynamics of RAS Mutation Clearance in Plasma from Metastatic Colorectal Cancer Patients
    Nicolazzo, Chiara
    Barault, Ludovic
    Caponnetto, Salvatore
    Macagno, Marco
    De Renzi, Gianluigi
    Gradilone, Angela
    Belardinilli, Francesca
    Cortesi, Enrico
    Di Nicolantonio, Federica
    Gazzaniga, Paola
    CANCERS, 2020, 12 (12) : 1 - 8
  • [5] About RAS Mutation Clearance in Plasma ctDNA From RAS-Mutant Colorectal Cancer Patients
    Gazzaniga, Paola
    Nicolazzo, Chiara
    Caponnetto, Salvatore
    Cortesi, Enrico
    JCO PRECISION ONCOLOGY, 2021, 5 : 389 - 390
  • [6] About RAS Mutation Clearance in Plasma ctDNA From RAS-Mutant Colorectal Cancer Patients Reply
    Bouchahda, Mohamed
    Saffroy, Raphael
    Karaboue, Abdoulaye
    Hamelin, Jocelyne
    Innominato, Pasquale
    Saliba, Faouzi
    Bosselut, Nelly
    Lemoine, Antoinette
    Levi, Francis
    JCO PRECISION ONCOLOGY, 2021, 5 : 391 - 392
  • [7] Plasma ctDNA RAS mutation analysis for the diagnosis and treatment monitoring of metastatic colorectal cancer patients
    Vidal, J.
    Muinelo, L.
    Dalmases, A.
    Jones, F.
    Edelstein, D.
    Iglesias, M.
    Orrillo, M.
    Abalo, A.
    Rodriguez, C.
    Brozos, E.
    Vidal, Y.
    Candamio, S.
    Vazquez, F.
    Ruiz, J.
    Guix, M.
    Visa, L.
    Sikri, V.
    Albanell, J.
    Bellosillo, B.
    Lopez, R.
    Montagut, C.
    ANNALS OF ONCOLOGY, 2017, 28 (06) : 1325 - 1332
  • [8] Monitoring of RAS mutant clones in plasma of patients with RAS mutant metastatic colorectal cancer
    Fernandez Montes, A.
    Elez, E.
    Vivancos, A.
    Martinez, N.
    Gonzalez, P.
    Covela, M.
    de la Camara, J.
    Cousillas, A.
    Mendez, J. C.
    Grana, B.
    Aranda, E.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2022, 24 (06): : 1209 - 1214
  • [9] Monitoring of RAS mutant clones in plasma of patients with RAS mutant metastatic colorectal cancer
    A. Fernández Montes
    E. Élez
    A. Vivancos
    N. Martínez
    P. González
    M. Covela
    J. de la Cámara
    A. Cousillas
    J. C. Méndez
    B. Graña
    E. Aranda
    Clinical and Translational Oncology, 2022, 24 : 1209 - 1214
  • [10] New biomarkers beyond RAS mutation for the treatment of metastatic colorectal cancer (mCRC)
    Yoshino, Takayuki
    CANCER SCIENCE, 2018, 109 : 2 - 2